Optical coherence tomography imaging for diabetic retinopathy and macular edema

Current Diabetes Reports

Volumn 10, Issue 4, 2010, Pages 264-269

  Buabbud, John C ^a   Al Latayfeh, Motasem M ^a   Sun, Jennifer K ^b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Diabetic macular edema; Diabetic retinopathy; OCT. Spectral domain; Optical coherence tomography; Time domain

Indexed keywords

DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DIAGNOSTIC VALUE; EYE PHOTOGRAPHY; HUMAN; IMAGE DISPLAY; INTERFEROMETRY; INTERMETHOD COMPARISON; OPTICAL COHERENCE TOMOGRAPHY; REPRODUCIBILITY; REVIEW; SUBRETINAL FLUID; THREE DIMENSIONAL IMAGING; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION; MACULAR EDEMA; PROCEDURES;

DIABETIC RETINOPATHY; HUMANS; MACULAR EDEMA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 77956395406     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-010-0129-z     Document Type: Review

References (32)

1. Huang D, Swanson EA, Lin CP, et al.: Optical coherence tomography. Science 1991, 254:1178-1181.
2. Fercher AF: Ophthalmic interferometry. Proceedings of the International Conference on Optics in Life Sciences. Garmisch- Partenkirchen, Germany. August 12-16, 1990.
3. Swanson EA, Izatt JA, Hee MR, et al.: In vivo retinal imaging by optical coherence tomography. Opt Lett 1993, 18:1864-1866.
4. HeeMR, Izatt JA, Swanson EA, et al.: Optical coherence tomography of the human retina. Arch Ophthalmol 1995, 113:325-332.
5. Chen TC, Cense B, Pierce MC, et al.: Spectral domain optical coherence tomography: ultra-high speed, ultra-high resolution ophthalmic imaging. Arch Ophthalmol 2005, 123:1715-1720.
6. Choma M, Sarunic M, Yang C, Izatt J: Sensitivity advantage of swept source and Fourier domain optical coherence tomography. Opt Express 2003, 11:2183-2189.
7. Sull AC, Vuong LN, Price LL, et al.: Comparison of spectral/ Fourier domain optical coherence tomography instruments for assessment of normal macular thickness. Retina 2010, 30: 235-245.
8. Davis MD, Bressler SB, Aiello LP, et al.: Comparison of timedomain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema. Invest Ophthalmol Vis Sci 2008, 49:1745-1752.
9. Krzystolik MG, Strauber SF, Aiello LP, et al.: Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Ophthalmology 2007, 114:1520-1525.
10. Browning DJ, Glassman AR, Aiello LP, et al.: Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 2007, 114:525-536. This paper establishes that there is only a moderate correlation between retinal CPT and visual acuity in DME.
11. Ferris FL III, Miller KM, Glassman AR, Beck RW: A proposed method of logarithmic transformation of optical coherence tomography data for use in clinical research. Ophthalmology 2010 Apr 2 [Epub ahead of print]. This article proposes evaluating log step changes in OCT measurements over time to account for baseline retinal thickness.
12. Danis RP, Glassman AR, Aiello LP, et al.: Diurnal variation in retinal thickening measurement by optical coherence tomography in center-involved diabetic macular edema. Arch Ophthalmol 2006, 124:1701-1707.
13. Browning DJ, Fraser CM, Propst BW: The variation in optical coherence tomography-measured macular thickness in diabetic eyes without clinical macular edema. Am J Ophthalmol 2008, 145:889-893.
14. Forooghian F, Cukras C, Meyerle CB, et al.: Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci 2008, 49:4290-4296. This article compares measurements of retinal thickness in eyes with DME obtained with TD-OCT versus SD-OCT technology.
15. Bressler NM, Edwards AR, Antoszyk AN, et al.: Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy. Am J Ophthalmol 2008, 145:894-901. This article establishes a normative database of retinal thickness measurements in eyes of patients with diabetes but minimal or no retinopathy.
16. van Dijk HW, Kok PH, Garvin M, et al.: Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci 2009, 50:3404-3409.
17. Van Dijk HW, Verbraak FD, Kok PH, et al.: Decreased retinal ganglion cell layer thickness in type 1 diabetic patients. Invest Ophthalmol Vis Sci 2010 Feb 3 [Epub ahead of print].
18. Otani T, Kishi S, Maruyama Y: Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 1999, 127:688-693.
19. Ghazi NG, Ciralsky JB, Shah SM, et al.: Optical coherence tomography findings in persistent diabetic macular edema: the vitreomacular interface. Am J Ophthalmol 2007, 144: 747-754.
20. Brown JC, Solomon SD, Bressler SB, et al.: Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography. Arch Ophthalmol 2004, 122:330-335.
21. Browning DJ, Fraser CM, Clark S: The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema. Ophthalmology 2008, 115:533-539.
22. Goebel W, Franke R: Retinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photography. Retina 2006, 26:49-57.
23. Browning DJ, Fraser CM: The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema. Am J Ophthalmol 2008, 145:149-154.
24. Virgili G, Menchini F, Dimastrogiovanni AF, et al.: Optical coherence tomography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review. Invest Ophthalmol Vis Sci 2007, 48:4963-4973.
25. Brar M, Yuson R, Kozak I, et al.: Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema. Retina 2010, 30:383-389.
26. Deak GG, Bolz M, Kriechbaum K, et al.: Effect of retinal photocoagulation on intraretinal lipid exudates in diabetic macular edema documented by optical coherence tomography. Ophthalmology 2010, 117:773-779.
27. Panozzo G, Parolini B, Gusson E, et al.: Diabetic macular edema: an OCT-based classification. Semin Ophthalmol 2004, 19:13-20.
28. Bolz M, Kriechbaum K, Simader C, et al.: In vivo retinal morphology after grid laser treatment in diabetic macular edema. Ophthalmology 2010, 117:538-544.
29. Roh MI, Kim JH, Kwon OW: Features of optical coherence tomography are predictive of visual outcomes after intravitreal bevacizumab injection for diabetic macular edema. Ophthalmologica 2010, 224:374-380.
30. Shah SP, Patel M, Thomas D, et al.: Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study. Br J Ophthalmol 2006, 90:33-36.
31. Forooghian F, Stetson PF, Meyer SA, et al.: Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema. Retina 2010, 30:63-70. This paper suggests that photoreceptor outer segment length is more closely correlated with visual acuity in DME than central subfield thickness.
32. Potsaid B, Gorczynska I, Srinivasan VJ, et al.: Ultrahigh speed Spectral/Fourier domain OCT: ophthalmic imaging at 70,000 to 312,500 axial scans per second. Opt Express 2008, 16:15149-15169.